Immunotherapy & Immuno-Oncology
Part of Healthcare - Oncology
 JNJ | Johnson & Johnson | $0.6t | $269.24 | -1.2% | 4.3M |
 ABBV | ABBVIE INC. | $443.4b | $262.14 | -1.1% | 2.3M |
 MRK | Merck & Co., Inc. | $315.6b | $152.78 | -2.1% | 7.1M |
 AZN | AstraZeneca PLC | $263.1b | $167.75 | -1.7% | 2.5M |
 AMGN | Amgen Inc | $207.9b | $438.15 | -0.4% | 1.6M |
 BMY | Bristol-Myers Squibb Co. | $133.4b | $67.67 | -0.5% | 4.4M |
 REGN | Regeneron Pharmaceuticals Inc | $78.2b | $812.58 | -2.2% | 291.5K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $25.3b | $61.80 | -0.4% | 1.2M |
 MRNA | Moderna, Inc. Common Stock | $22.0b | $147.66 | -5.7% | 21.0M |
 IBRX | ImmunityBio, Inc. Common Stock | $7.5b | $8.23 | +0.7% | 8.6M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 CGON | CG Oncology, Inc. Common stock | $6.3b | $78.50 | -0.6% | 229.4K |
 RCUS | Arcus Biosciences, Inc. | $3.5b | $30.76 | -2.6% | 560.6K |
 NKTR | Nektar Therapeutics | $2.4b | $74.34 | -1.5% | 287.8K |
 PGEN | Precigen, Inc. Common Stock | $2.4b | $7.59 | +1.6% | 6.8M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.2b | $13.77 | -2.4% | 4.1M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.8b | $8.24 | -4.1% | 9.2M |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.8b | $24.71 | +0.5% | 344.4K |
 SNDX | Syndax Pharmaceuticals, Inc. | $1.7b | $20.09 | +0.9% | 630.3K |
 XNCR | Xencor, Inc. | $1.4b | $28.34 | -2.9% | 1.9M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.2b | $125.44 | +1.9% | 283.0K |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $9.14 | +2.1% | 722.6K |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.1b | $14.73 | +1.1% | 529.3K |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $1.0b | $23.20 | -0.4% | 524.2K |
 REPL | Replimune Group, Inc. | $1.0b | $15.84 | +0.5% | 1.8M |
 JANX | Janux Therapeutics, Inc. Common Stock | $0.9b | $18.80 | +1.0% | 424.0K |
 OMER | Omeros Corporation | $0.9b | $18.42 | -5.5% | 1.3M |
 CADL | Candel Therapeutics, Inc. Common Stock | $0.7b | $13.55 | -2.4% | 896.9K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.7b | $7.70 | -1.3% | 505.8K |
 CTMX | CytomX Therapeutics, Inc. | $0.7b | $3.40 | -1.8% | 2.0M |
 CBIO | Crescent Biopharma, Inc. Common Stock | $0.5b | $18.11 | +5.9% | 296.6K |
 CMPX | Compass Therapeutics, Inc. Common Stock | $344.0m | $2.47 | -3.8% | 1.3M |
 AGEN | Agenus Inc. | $312.3m | $8.32 | -1.4% | 716.6K |
 ALXO | ALX Oncology Holdings Inc. Common Stock | $261.1m | $1.98 | -1.5% | 333.3K |
 MGNX | MacroGenics, Inc. | $242.8m | $4.08 | -3.1% | 237.3K |
 CGEN | Compugen Ltd | $222.3m | $2.81 | -0.7% | 659.9K |
 CHRS | Coherus Oncology, Inc. Common Stock | $217.5m | $1.45 | +5.1% | 843.4K |
 GLSI | Greenwich LifeSciences, Inc. | $198.2m | $18.23 | -2.3% | 54.1K |
 INDP | Indaptus Therapeutics, Inc. Common Stock | $171.9m | $1.11 | +5.5% | 203.8K |
 HURA | TuHURA Biosciences, Inc. Common Stock | $138.2m | $2.13 | +3.9% | 151.6K |
 GNLX | Genelux Corporation Common Stock | $131.8m | $2.74 | +0.4% | 263.8K |
 ANIX | Anixa Biosciences, Inc. | $116.4m | $3.63 | -1.0% | 288.5K |
 CUE | Cue Biopharma, Inc. | $112.7m | $27.78 | +8.3% | 197.4K |
 ONCY | Oncolytics Biotech, Inc. Common Shares | $92.5m | $0.85 | -0.6% | 408.8K |
 MAIA | MAIA Biotechnology, Inc. | $76.0m | $1.41 | -1.3% | 535.7K |
 ELTX | Elicio Therapeutics, Inc. Common Stock | $73.5m | $3.05 | -1.0% | 174.5K |
 XBIT | XBiotech Inc | $68.1m | $2.30 | 0.0% | 21.1K |
 XLO | Xilio Therapeutics, Inc. Common Stock | $59.5m | $9.00 | +0.7% | 7.6K |
 CNTX | Context Therapeutics Inc. Common Stock | $55.1m | $0.44 | -3.2% | 1.0M |
 TIL | Instil Bio, Inc. Common Stock | $49.0m | $7.82 | 0.0% | 10.5K |